27 search results
You searched for these word(s): risk assessmentMARINA Risk Assessment Strategy
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/marina-risk-assessment-strategy… stages on human health and combined with environmental risks. Within MARINA a two-phase risk assessment strategy has been developed. In Phase 1 … MARINA Risk Assessment Strategy … MARINA Risk Assessment Strategy …
Publication date: 09-08-2017NanoFASE: SimpleBox4Nano screening fate assessment model
https://www.rivm.nl/en/international-projects/nanoregii/safe-innovation-approach-toolbox/nanofase-simplebox4nano-screening-fate-assessment-model… of the SimpleBox model, which underpins the EU's chemical risk and safety decision-support tool EUSES. SimpleBox4Nano … at regional to continental scale for screening level fate assessment. It can also be used to determine the maximum … NanoFASE: SimpleBox4Nano screening fate assessment model …
Publication date: 09-08-2017CENARIOS® risk management and monitoring system
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/cenarios-risk-management-and-monitoring-system… CENARIOS® (Certifiable Nanospecific Risk Management and Monitoring System) enables identification, analysis and assessment of the potential risks and opportunities involved in nanotechnology and their … CENARIOS® risk management and monitoring system … CENARIOS® risk management and monitoring system …
Publication date: 09-08-2017Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon
https://www.rivm.nl/en/news/children-aged-16-18-years-at-higher-risk-for-medical-reasons-will-receive-first-vaccination… born in 2003, 2004 and 2005 who are in the medical high-risk group. The first young people in this group will be … These young people are included in the medical high-risk group that the Health Council has defined for adults. … Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon …
Publication date: 04-19-2021People with a medical risk between the ages of 18-60 years invited from early May on
https://www.rivm.nl/en/news/people-with-medical-risk-between-ages-of-18-60-years-invited-from-early-may-on… in the first week of May, people under 60 who are at risk for medical reasons, i.e. the group eligible for the … in this group are prioritised because they have a higher risk of severe illness from COVID-19. This includes people … to respiratory tract infections. People in the medical high-risk groups already received their invitations for COVID-19 …
Publication date: 04-20-2021New hold on vaccination with AstraZeneca for people under 60 years
https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years… Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …
Publication date: 04-02-2021Nanosafer tool
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/nanosafer-tool… Online control banding and risk management tool for manufactured nanomaterials. Hazard assessment and case-specific exposure potentials are combined into an integrated assessment of risk levels expressed in control bands with associated risk …
Publication date: 09-08-2017Newsletter on COVID-19 vaccination issue 12 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/12… Vaccination starts for medical high risk groups … for elderly people and for people in the medical high-risk group due to neurological disorders accompanied by … has been made for four categories in the the medical high-risk groups . This applies to people whose immune system is …
Publication date: 04-02-2021One box-model for accident situations in laboratories (Walser et al 2012)
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/one-box-model-for-accident-situations-in-laboratories-walser-et-al-2012… device is appropriate and sufficient for a screening assessment of workplace exposure to NP for events with NP …
Publication date: 09-19-2017Consexpo Nano Tool
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/consexpo-nano-tool… is presented in different measures. The outcome of the assessment is an alveolar load in the lungs as one of the …
Publication date: 09-08-2017Control Banding Nanotool
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/control-banding-nanotool… To assess risks associated with nanotechnology operations. The tool … “probability” scores in a matrix to obtain a level of risk and associated controls out of 4 possible levels of increasing risk and associated controls. Control banding (CB) …
Publication date: 09-08-2017Different vaccine very soon available to people under 60, instead of AstraZeneca
https://www.rivm.nl/en/news/different-vaccine-very-soon-available-to-people-under-60-instead-of-astrazeneca… impact on five groups. This involves people at higher risk for medical reasons who are unable to travel, people … People at higher risk for medical reasons who are unable to travel This …
Publication date: 04-13-2021The Swiss precautionary matrix for synthetic nanomaterials
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/swiss-precautionary-matrix-for-synthetic-nanomaterials… Allows to estimate 'nanospecific risk potentials' for synthetic nanomaterials and …
Publication date: 09-08-2017Lean Business Canvas, safety and society check
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/lean-business-canvas-safety-and-society-check… as applied within the NanoNextNL Valorisation Programme. Risk levels for safety and society are indicated with arrows …
Publication date: 09-08-2017Newsletter on COVID-19 vaccination issue 15, 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/15… born in 2003, 2004 and 2005 who are in a medical high-risk group . The first young people in this group will soon … in the first week of May, people under 60 who are at risk for medical reasons , i.e. the group eligible for the … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines …
Publication date: 04-22-2021Stoffenmanager Nano
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/safe-innovation-approach-toolbox/stoffenmanager-nano… Tool using an Exposure Process Model. To assess health risks qualitatively after exposure to synthetic NPs. It …
Publication date: 09-08-2017Newsletter on COVID-19 vaccination issue 14 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/14… 60 has a direct impact on five groups: people at higher risk for medical reasons who are unable to travel, people … can be attributed to the vaccine. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency … in 2003, 2004 and 2005) who are in one of the medical high-risk groups . This vaccine has been approved for people aged …
Publication date: 04-20-2021The National Network of Safety and Security Analysts
https://www.rivm.nl/en/about-rivm/organisation/centre-for-environmental-safety-and-security/national-network-of-safety-and-security-analysts… In the past, these analyses were reported in the National Risk Assessment, but since 2016 they are presented in the National Risk Profile (NRP) and its underlying thematic reports. …
Publication date: 09-11-2017Newsletter on COVID-19 vaccination issue 13 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/13… This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency …
Publication date: 04-12-2021SimpleBox4nano
https://www.rivm.nl/en/soil-and-water/simplebox4nano… also serves as fate module in Life Cycle Impact Assessment models [ 5 , 6 ]. Designed originally as a …
Publication date: 09-07-2017